Mökah, a company of the Kanalservice Group and portfolio company of Ufenau Capital Partners, has acquired H. Jakober as part of the group’s ongoing growth strategy. H. Jakober is a provider of comprehensive services in the areas of IA traditional sewer maintenance, surface treatment and water high pressure cleaning. With approximately 300 employees, 250 vehicles […]
Datwyler, a provider of high-quality, system-critical elastomer components, has signed on 6 April 2022 an agreement to acquire the US company QSR from Q Holding and its private equity owner, 3i. The planned acquisition of QSR will
Bär & Karrer advised on the sale of Brust-Zentrum Zurich, a Swiss medical center specialised in the diagnosis and professional treatment of the breast. The owners of Brust-Zentrum Zurich have entered a strategic alliance
GarLa Group acquired the majority of Enz Group. Based on Giswill, Enz Group decided to work together with a strategic and long-term oriented partner and give up the majority of shares in the group.
Walder Wyss acted as Swiss counsel and Listing Agent to Montana Aerospace on the closing of the purchase of S.R.I.F. NV (the Asco Group) and the issuance and listing of 4,431,600 shares on 7
British oil and gas company BP has sold its Swiss retail business to Oel-Pool, suppliers of liquid fuels. The Swiss company together with its subsidiary company Moveri will officially take over BP’s gas station
Collana IT has acquired all the shares in the Swiss Neolution, a company specialized in complex web and mobile solutions with outstanding testimonials from financial institutions, insurances and companies in the field of telecommunication,
DentaCore, a privately held corporation specialising in acquisitions, investments and consolidation in the fragmented dental medicine sector, has acquired Cera-Tech, an innovative dental manufacturer. Headquartered in Switzerland, DentaCore focuses on the integration of outstanding practices,
Kellerhals Carrard acted as Swiss legal advisor to MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company elevating care with innovative immunology therapeutics, in the closing of its previously announced business combination with Helix Acquisition Corp. (“Helix”), a
Kinarus, a privately owned clinical-stage biopharmaceutical company active in the development of novel treatments for patients suffering from serious viral, respiratory and ophthalmic diseases, signed a Transaction Agreement with SIX-listed Perfect Holding regarding Perfect Holding’
